Oncolytics Biotech ONCY
NASDAQ ONCY
$0.50 -0.01 (-2.19%)
At close: Oct 22, 2026 · 4:00 PM EDT

Oncolytics Biotech (ONCY) Non-Current Deffered Revenue (2017 - 2026)

Updated

Oncolytics Biotech's Non-Current Deffered Revenue came in at $4.91 million for Q2 2026.

Analysis

Oncolytics Biotech (ONCY) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends

  • Going back by year, Non-Current Deffered Revenue was $4.68 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Oncolytics Biotech 60.30 Mn 31.42 Mn - 4.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.91 Mn
Dec 31, 2025 4.91 Mn
Sep 30, 2025 4.84 Mn
Jun 30, 2025 4.92 Mn
Mar 31, 2025 4.70 Mn
Dec 31, 2024 4.68 Mn
Sep 30, 2024 4.98 Mn
Jun 30, 2024 4.91 Mn
Mar 31, 2024 4.97 Mn
Sep 30, 2023 4.99 Mn
Jun 30, 2023 5.08 Mn
Mar 31, 2023 4.98 Mn
Dec 31, 2022 4.97 Mn
Sep 30, 2022 4.92 Mn
Jun 30, 2022 5.22 Mn
Mar 31, 2022 5.39 Mn
Dec 31, 2021 5.28 Mn
Sep 30, 2021 5.28 Mn
Jun 30, 2021 5.43 Mn
Mar 31, 2021 5.33 Mn
API Access

Oncolytics Biotech Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ONCY&period=max&api_key=YOUR_API_KEY